TGTX

NASDAQ 已收盘

TG Therapeutics

64.88 USD
▼-1.24-1.88%
盘后 64.89 +0.01%
2026-11-19
市值
$9.02B
市盈率
97.46
EPS
0.66
股息率
—
52 周区间
26.76 – 68.03
成交量
1.66M
Beta
1.81
目标价
69.43
52W 低 26.7652W 高 68.03
价格走势

公司简介

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company’s development pipeline comprises Ublituximab ...